Sterling Capital Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59K Sell
169
-131
-44% -$1.25K ﹤0.01% 3046
2026
Q1
$2.74K Hold
300
﹤0.01% 2916
2025
Q4
$2.23K Buy
300
+188
+168% +$1.35K ﹤0.01% 3052
2025
Q3
$749 Buy
112
+1
+0.9% +$7 ﹤0.01% 3118
2025
Q2
$735 Sell
111
-326
-75% -$2.31K ﹤0.01% 3108
2025
Q1
$4K Sell
437
-347
-44% -$3.47K ﹤0.01% 2277
2024
Q4
$8.23K Buy
784
+694
+771% +$8.21K ﹤0.01% 2250
2024
Q3
$1.08K Buy
+90
New +$778 ﹤0.01% 2482

Other funds holding BVS

Sterling Capital Management's BVS Position: Q2 2026 in Review

Sterling Capital Management reduced its Bioventus (BVS) stake by 44% in Q2 2026, selling an estimated $1.25K and leaving 169 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

Sterling Capital Management first reported a position in BVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.23K in Q4 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Sterling Capital Management held 169 shares of Bioventus worth $1.59K as of Q2 2026.
  • Sterling Capital Management sold 131 Bioventus shares in Q2 2026, an estimated $1.25K.
  • Bioventus made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3046 holding.
  • Sterling Capital Management first reported a position in Bioventus in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Bioventus position peaked at $8.23K in Q4 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.